Clinical Trials: Find a Clinical Trial

At any time Memorial Sloan-Kettering Cancer Center is conducting hundreds of clinical trials to improve care for many types of cancer. Use the tool below to browse our clinical trials that are currently enrolling new patients. Each listing explains the purpose of the trial, the trial’s eligibility criteria, and how to get more information.

The list below includes clinical trials for adult cancers. Please visit our pediatric cancer care section to find a pediatric clinical trial.

Showing 181 - 200 of 446 trials
Title Investigatorsort icon Disease(s)
Radium-223 (Alpharadin) in Men with Castration-Resistant Prostate Cancer and Bone Metastases
[Protocol 12-199]
Morris, Michael
  • Prostate Cancer
    • Metastatic Disease after Hormone-Reducing Therapy
A Phase I Study of ASG-5ME Therapy Patients with Advanced Prostate Cancer
[Protocol 10-138]
Morris, Michael
  • Prostate Cancer
    • Metastatic Disease after Hormone-Reducing Therapy
A Phase I Study of AGS-16C3F in Patients with Clear Cell or Papillary Renal Cell Cancer
[Protocol 12-162]
Molina, Ana Maria
  • Kidney Cancer
A Phase IB Study of SGN-75 plus Everolimus in Patients with CD70-Positive Metastatic Renal Cell Cancer
[Protocol 12-263]
Molina, Ana Maria
  • Kidney Cancer
A Phase IB/II study of E7080 plus Everolimus in Patients with Unresectable Advanced/Metastatic Renal Cell Carcinoma
[Protocol 10-084]
Molina, Ana Maria
  • Kidney Cancer
A Phase II Trial of Everolimus and Bevacizumab in Advanced Non-Clear Cell Renal Cell Cancer
[Protocol 10-226]
Molina, Ana Maria
  • Kidney Cancer
A Phase Ib Study of Trastuzumab-MCC-DM1, Paclitaxel, and Pertuzumab in Patients with HER2-Positive, Locally Advanced or Metastatic Breast Cancer Who Previously Received Trastuzumab
[Protocol 09-093]
Modi, Shanu
  • Breast Cancer
A Phase I Study of Intraperitoneal Radioimmunotherapy with 131I-8H9 for Patients with Desmoplastic Small Round Cell Tumors and Other Solid Peritoneal Tumors
[Protocol 09-090]
Modak, Shakeel
A Phase II Study of Bevacizumab, Irinotecan, and Temozolomide for Relapsed or Refractory Neuroblastoma
[Protocol 10-015]
Modak, Shakeel
  • Neuroblastoma
A Phase I Study of Anti-GD2 3F8 Antibody and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma
[Protocol 09-011]
Modak, Shakeel
  • Neuroblastoma
A Pilot Phase II Study of Targeted Radiotherapy with 131I-MIBG and Arsenic Trioxide in Patients with Resistant Neuroblastoma or Malignant Chromaffin Cell Tumors
[Protocol 04-148]
Modak, Shakeel
  • Neuroblastoma
A Phase I Study of Panitumumab in Children with Solid Tumors
[Protocol 08-020]
Meyers, Paul
Genetic Variability as a Determinant of Chemotherapy Toxicity and Response in Pediatric Cancer and Bone Marrow Transplantation Patients
[Protocol 03-123]
Meyers, Paul
  • Hematology
    • Hematologic Malignancies
  • Sarcomas
A Phase II Study of BKM120 in Patients with Recurrent Glioblastoma and an Activated PI3K Pathway
[Protocol 12-002]
Mellinghoff, Ingo
  • Pediatric Brain Tumors
    • Brain Cancer
A Pilot Study of Weekly High-Dose Erlotinib for Recurrent High-Grade Gliomas with the EGFR variant III Mutation
[Protocol 10-125]
Mellinghoff, Ingo
  • Brain Tumors, Primary
    • Gliomas
  • Pediatric Brain Tumors
    • Brain Cancer
A Phase II Study of Repeat Breast-Preserving Surgery and 3D-Conformal Partial Breast Re-Irradiation for Local Recurrence of Breast Cancer
[Protocol 10-152]
McCormick, Beryl
  • Breast Cancer
Use of Patient-Reported Outcomes to Facilitate Survivorship Care and Determine Risk of Adverse Outcomes in Cancer Survivors
[Protocol 12-185]
McCabe, Mary
  • Colorectal Cancer
    • Colon Cancer
  • Prostate Cancer
    • Quality of Life
  • Survivorship
A Pilot Study of Single-Dose Ipilimumab and/or Cryoablation in Women with Early-Stage Breast Cancer Scheduled for Mastectomy
[Protocol 11-202]
McArthur, Heather
  • Breast Cancer
A Phase III Study of Ofatumumab versus Rituximab Salvage Chemoimmunotherapy Followed by Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
[Protocol 11-079]
Matasar, Matthew
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase II Trial of a WT-1 Vaccine in Patients with Acute Myeloid Leukemia
[Protocol 10-143]
Maslak, Peter
  • Leukemia
    • Acute Myelogenous Leukemia